<p>(A) Protein expression of Skp2 was assayed by Western blotting in PC-3 cells re-expressing wild type AR (PC-3<sup>AR</sup>) cells and overexpressing either control vector or Skp2 in the absence or presence of 10 nM R1881 for 96 h. Effect of androgen on cell proliferation (B) or cell cycle progression (C) of these clones treated with increasing concentration of R1881 for 96 h was determined by 96-well proliferation assay and PI-staining flow cytometry analysis, respectively. Asterisks * and ** denote a significant difference <i>p</i><0.05 and <i>p</i><0.01, respectively, between the treatment and the control cells.</p
<p>AR was overexpressed in DPCs by transfected with pcDNA3-hAR and cultured in the presence of DHT o...
<p>(A) LNCap, PC3, and PNT2 cells were treated with or without testosterone (0–1000 nM) for 120 h, b...
<p>(A) Protein expression of Skp2 assayed by Western blotting in PC-3 LPCX control and PC-3 LPCX Skp...
<p>(A) LNCaP 104-R1 cells, PC-3 cells with control plasmid LNCX-2 (PC-3<sup>LNCX-2</sup>), PC-3 cell...
<p>Protein expression of AR, Skp2, Cdk2, phospho-Cdk2 Tyr15, phospho-Cdk2 Thr14, phospho-Cdk2 Thr160...
<p>Protein expression of total Akt, Akt1, Akt2, phospho-Akt Ser473, phospho-Akt Thr308, p42/44 MAPK,...
<p>(A) Protein expression level of Skp2 and p27<sup>Kip1</sup> in LNCaP 104-R1 cells infected with p...
<p>(A) Gene expression of CDKN1B was determined in LNCaP 104-R1 cells treated with 0, 0.1, or 10 nM ...
The majority of prostate cancer (PCa) patient receiving androgen ablation therapy eventually develop...
[[abstract]]The majority of prostate cancer (PCa) patient receiving androgen ablation therapy eventu...
[[abstract]]Androgen ablation therapy is the primary treatment for metastatic prostate cancer. Howev...
<p>(A) Levels of phosphor-ATM (Ser 1981), phosphor-ATR (Ser 428), phosphor-Chk2 (Thr 68), phosphor-C...
<p>AS LNCaP C-33 cells were seeded at a density of 2×10<sup>4</sup> cells/cm<sup>2</sup> in regular ...
The androgen receptor (AR) plays a central role in prostate, muscle, bone and adipose tissue. Moreov...
<p>(A) PC3-Lenti-AR (PC3-AR) cells and parental PC-3 (PC3) cells were treated with 10 nM DHT or vehi...
<p>AR was overexpressed in DPCs by transfected with pcDNA3-hAR and cultured in the presence of DHT o...
<p>(A) LNCap, PC3, and PNT2 cells were treated with or without testosterone (0–1000 nM) for 120 h, b...
<p>(A) Protein expression of Skp2 assayed by Western blotting in PC-3 LPCX control and PC-3 LPCX Skp...
<p>(A) LNCaP 104-R1 cells, PC-3 cells with control plasmid LNCX-2 (PC-3<sup>LNCX-2</sup>), PC-3 cell...
<p>Protein expression of AR, Skp2, Cdk2, phospho-Cdk2 Tyr15, phospho-Cdk2 Thr14, phospho-Cdk2 Thr160...
<p>Protein expression of total Akt, Akt1, Akt2, phospho-Akt Ser473, phospho-Akt Thr308, p42/44 MAPK,...
<p>(A) Protein expression level of Skp2 and p27<sup>Kip1</sup> in LNCaP 104-R1 cells infected with p...
<p>(A) Gene expression of CDKN1B was determined in LNCaP 104-R1 cells treated with 0, 0.1, or 10 nM ...
The majority of prostate cancer (PCa) patient receiving androgen ablation therapy eventually develop...
[[abstract]]The majority of prostate cancer (PCa) patient receiving androgen ablation therapy eventu...
[[abstract]]Androgen ablation therapy is the primary treatment for metastatic prostate cancer. Howev...
<p>(A) Levels of phosphor-ATM (Ser 1981), phosphor-ATR (Ser 428), phosphor-Chk2 (Thr 68), phosphor-C...
<p>AS LNCaP C-33 cells were seeded at a density of 2×10<sup>4</sup> cells/cm<sup>2</sup> in regular ...
The androgen receptor (AR) plays a central role in prostate, muscle, bone and adipose tissue. Moreov...
<p>(A) PC3-Lenti-AR (PC3-AR) cells and parental PC-3 (PC3) cells were treated with 10 nM DHT or vehi...
<p>AR was overexpressed in DPCs by transfected with pcDNA3-hAR and cultured in the presence of DHT o...
<p>(A) LNCap, PC3, and PNT2 cells were treated with or without testosterone (0–1000 nM) for 120 h, b...
<p>(A) Protein expression of Skp2 assayed by Western blotting in PC-3 LPCX control and PC-3 LPCX Skp...